Healthcare Industry News: Spinal Stabilization
News Release - December 16, 2010
1,500th Implant Milestone Reached by Centinel Spine’s STALIF C(TM)
Record Results Posted For Year Over Year and Third Quarter, 2010 RevenueNEW YORK--(Healthcare Sales & Marketing Network)-- Centinel Spine, Inc. today announced implantation of the 1,500th STALIF C™, the company’s cervical Integrated Interbody Fusion™ device. At the same time, Centinel Spine also announced record sales results for STALIF C™ with third quarter, year-on-year revenue growth of 132% and Q3, 2010 versus Q2, 2010 growth of 31%.
Commenting on the rapid acceptance of STALIF C™ by the surgical community, Centinel Spine Chairman and CEO John J. Viscogliosi, said, “STALIF C is simply the right solution at the right time. With both doctors and patients looking for less invasive solutions, allowing significantly easier and faster procedures and recovery times, STALIF C has shown itself to be in the forefront of meeting these needs.”
“Because the device is built on the same technological platform as our original market-creating product, the STALIF TT™, we expect that it will show similar outstanding growth going forward,” Mr. Viscogliosi added.
Acknowledging the milestone, Centinel President Michael D. Will said: “STALIF C is a small device that is making a huge difference in patients’ quality of life. Based on the record rate of revenue growth and record pace of units sold, it is apparent that surgeons have identified a distinct clinical advantage to patients by utilizing STALIF C.”
“The no-profile construct, our ABO™ screw system that does not require supplemental fixation and the availability of two sagittal profile options – are combining to provide an easier, faster and less invasive solution that is key to its success,” Mr. Will added.
About Centinel Spine, Inc.
STALIF C™ is one of a series of anterior fusion devices developed, marketed and sold by Centinel Spine, Inc. Founded in 2008, Centinel Spine, Inc. is an innovative spinal device company committed to the design and development of simple, biomechanically sound solutions for Spinal Stabilization and fusion. The company is recognized as the creator and leader in the expanding Integrated Interbody Fusion™ spinal market segment.
STALIF™, STALIF C™, ABO™ and Integrated Interbody Fusion™ are registered trademarks or trademarks of Centinel Spine, Inc. in the United States and/or other countries.
For more information on Centinel Spine:
http://www.centinelspine.com/
Source: Centinel Spine
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
